|
|||||||
 |
Etanercept, marketed under the name Enbrel, is a drug that belongs to the class of drugs known as tumor necrosis factor (TNF)-alpha blocker. It is used primarily to treat rheumatoid arthritis, but has also been approved for use in treating polyarticular juvenile idiopathic arthritis, psoriatic arthritis, ankylosing spondylitis, and psoriasis. On May 1st, the U.S. Food [...] Today marks the 4th observance of World Psoriasis Day. The purpose is to increase awareness of this genetic immune system disease which affects 7.5 million people in the U.S. and 125 million people around the world. Psoriasis is a non-contagious skin condition that can lead to other serious conditions, including heart disease, diabetes, liver disease and [...] I have posted in the past about the links discovered between various forms of arthritis and genetics. Here are a couple more genes that have been identified with an increased risk in arthritis. HLA-B27 The first gene, HLA-B27, was determined in the 1960’s to have a link with spondyloarthropathies, which are a group of diseases that affect the [...] Researchers from Israel have discovered that psoriatic arthritis patients may have signs of an abnormal heart rhythm, or arrhythmia. [...] The first international guidelines for the treatment of psoriatic arthritis has been developed and published by a group of rheumatologists, dermatologists, and patient advocates. [...] |
  
|
|||||
|
Copyright © 2010 Current Arthritis News and Research - All Rights Reserved
|
|||||||
Recent Comments